990x120 sept 22

Event Overview

Extremophiles are best known to scientists for their contributions to PCR, but researchers are now harnessing the power of their unique biology to create new therapeutics from vaccine delivery to anti-cancer drugs. In this webinar from The Scientist, extremophile researchers Shiladitya DasSarma and Jaclyn Winter will discuss how they harness the unique biology of extremophiles for the discovery and development of new therapeutics and vaccines.

Topics to be covered
  • Harnessing the chemical potential of unprecedented microbes from the Great Salt Lake
  • Archaeal nanoparticles for therapeutics and vaccines
Tuesday, September 22, 2020
 2:30 - 4:00 PM, Eastern Standard Time


Jaclyn Winter, PhD
Assistant Professor
Department of Medicinal Chemistry
University of Utah

Shiladitya DasSarma, PhD
Professor, Department of Microbiology and Immunology
University of Maryland School of Medicine
Professor, Institute of Marine and Environmental Technology
University System of Maryland

Register Now

Extreme Biotech: Understanding Extremophile Biology to Impact Human Health

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.